PMID: 2509238Sep 1, 1989Paper

Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation

European Journal of Haematology
H CohenS J Machin

Abstract

We report studies on vascular endothelial function and ultrastructure in 2 cases of fatal cyclosporin (CS)-associated thrombotic microangiography following allogeneic bone marrow transplantation (BMT). Spontaneous vascular release of prostacyclin (PGI2) from a vein sample ex vivo was absent, and scanning electron microscopy (SEM) showed surface changes indicative of vascular endothelial damage (case 1). PGI2 release from cultured human umbilical vein endothelial cells incubated with patients' serum in vitro was normal in both cases. Plasma von Willebrand factor (vWF) antigen and ristocetin cofactor activity levels were raised in both patients, 5.06 and 7.02 (case 1) and 3.60 and 2.01 (case 2) (normal ranges 0.59-1.57 and 0.42-1.74 U/ml), respectively, but multimer patterns were normal. The SEM appearances coupled with the absent PGI2 release and raised vWF levels suggest that vascular endothelial damage is central to the pathogenic process in thrombotic microangiopathy following allogeneic BMT but the mechanisms appear to be distinct from those in the haemolytic uraemic syndrome and de novo thrombotic thrombocytopenic purpura. The precise role of CS in this process remains to be identified.

References

Oct 10, 1987·British Medical Journal·J I CraigK Bell
Mar 1, 1985·Journal of Clinical Pathology·G H NeildJ S Cameron
May 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·E A JaffeR L Nachman
May 1, 1983·British Journal of Haematology·J M HowsE C Gordon-Smith
Nov 15, 1983·Thrombosis Research·G H NeildD G Williams
Dec 1, 1984·Archives of Disease in Childhood·P E RoseF G Hill
Oct 25, 1952·British Medical Journal·W S SYMMERS

❮ Previous
Next ❯

Citations

Jan 1, 1996·Cancer Investigation·J J Byrnes, A M Hussein
Jun 16, 2001·Hematology·ALESSANDRO Busca, CORNELIO Uderzo
Nov 20, 2002·Bone Marrow Transplantation·A S DalyJ H Lipton
Sep 17, 2003·Transplant Infectious Disease : an Official Journal of the Transplantation Society·K RamasubbuR K Avery
Feb 3, 2007·Current Opinion in Oncology·Kiarash Kojouri, James N George
Sep 12, 2007·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Yujiro KidaHiroshi Saito
Nov 26, 2009·Chronic Respiratory Disease·Ariel Modrykamien
Aug 5, 2015·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Osama ElsallabiKetki K Tendulkar
Oct 14, 2005·Nephrology·Masako OtaniHidekazu Shigematsu
Dec 17, 2014·Cancer Control : Journal of the Moffitt Cancer Center·Laura S Connelly-Smith, Michael L Linenberger
Dec 17, 2002·Leukemia & Lymphoma·Sarah L AllfordDavid I Marks
Oct 11, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Eleanor G Seaby, Rodney D Gilbert
Apr 1, 1996·Hematology/oncology Clinics of North America·J L Moake, J J Byrnes
Nov 1, 1994·Kidney International·R A Zager

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.